EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, RP Bio lnc's Enterprise Value is ₩95,553 Mil.
RP Bio lnc's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-584 Mil. Therefore, RP Bio lnc's EV-to-FCF for today is -163.53.
The historical rank and industry rank for RP Bio lnc's EV-to-FCF or its related term are showing as below:
XKRX:314140'
s EV-to-FCF Range Over the Past 10 Years
Min: -225.18 Med: -32.39 Max: -4.55
Current: -165.6
During the past 4 years, the highest EV-to-FCF of RP Bio lnc was -4.55. The lowest was -225.18. And the median was -32.39.
XKRX:314140's EV-to-FCF is ranked worse than 100% of 514
companies
in the Drug Manufacturers industry
Industry Median: 23.995
vs XKRX:314140: -165.60
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-05-13), RP Bio lnc's stock price is ₩8940.00.
RP Bio lnc's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₩780.000. Therefore, RP Bio lnc's PE Ratio for today is 11.46.
RP Bio lnc EV-to-FCF Historical Data
The historical data trend for RP Bio lnc's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, RP Bio lnc's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
RP Bio lnc's EV-to-FCF Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, RP Bio lnc's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where RP Bio lnc's EV-to-FCF falls into.
RP Bio lnc EV-to-FCF Calculation
RP Bio lnc's EV-to-FCF for today is calculated as:
RP Bio lnc's current Enterprise Value is ₩95,553 Mil.
RP Bio lnc's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-584 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RP Bio lnc (XKRX:314140) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
RP Bio lnc's share price for today is ₩8940.00.
RP Bio lnc's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩780.000.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
RP Bio lnc EV-to-FCF Related Terms
Thank you for viewing the detailed overview of RP Bio lnc's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XKRX:314140 has been successfully added to your 